TrialDiabetes, obesity & metabolism2022

Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.

Victoria E R Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.